Full pledge release on promoter Docon's 7.94 crore Thyrocare shares

Pledge ReleasedOwnership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹620.00

prior close

₹610.95

announcement price

In-mkt

timing

Nifty Microcap 250market+0.4%-2.0% vs market

Healthcare Service Provider peers, median of 28sector+0.1%-1.7% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-0.0

15m

+0.0

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.4-2.0+0.1-1.7

Next day

-6.5-0.2-6.2-0.2-6.2

-8.5+0.3-8.9-0.1-8.5

-8.7+0.6-9.3+0.5-9.2

-5.5+0.8-6.3+0.0-5.5

-3.9+0.4-4.3+0.6-4.5

-6.0+0.7-6.7+0.1-6.1

15d

-8.0+2.0-10.0+1.4-9.4

-10.5+0.7-11.2+1.1-11.6

-24.2-3.4-20.8-3.0-21.2

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Docon Technologies has fully released the pledge on 7,94,69,696 equity shares (about 49.93 percent of Thyrocare capital), held as security for NCDs of about 1,050 crore issued by parent API Holdings. API fully redeemed these NCDs on August 14, 2026. After release, Docon continues to hold 8,12,00,000 shares (51.02 percent) with zero encumbrance remaining on promoter holdings.

Likely market impact

Positive - removes pledge overhang. Promoter stake now fully unencumbered, lowering forced-sale risk for shareholders.